JPY8,605.00
2.20% today
Tokyo, Nov 26, 07:15 am CET
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Otsuka Stock price

JPY8,613.00
-537.00 5.87% 1M
+2,461.00 40.00% 6M
+3,324.00 62.85% YTD
+2,981.00 52.93% 1Y
+4,524.00 110.64% 3Y
+3,857.00 81.10% 5Y
+4,793.00 125.47% 10Y
Tokyo, Closing price Tue, Nov 26 2024
-186.00 2.11%
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Key metrics

Market capitalization JPY4.76t
Enterprise Value JPY4.62t
P/E (TTM) P/E ratio 31.49
EV/FCF (TTM) EV/FCF 16.34
EV/Sales (TTM) EV/Sales 2.04
P/S ratio (TTM) P/S ratio 2.10
P/B ratio (TTM) P/B ratio 1.90
Dividend yield 1.36%
Last dividend (FY24) JPY120.00
Revenue growth (TTM) Revenue growth 16.33%
Revenue (TTM) Revenue JPY2.27t
EBIT (operating result TTM) EBIT JPY382.97b
Free Cash Flow (TTM) Free Cash Flow JPY282.94b
Cash position JPY515.11b
EPS (TTM) EPS JPY279.46
P/E forward 19.60
P/S forward 2.07
EV/Sales forward 2.01
Show more

Is Otsuka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Otsuka Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

Buy
70%
Hold
30%

Financial data from Otsuka

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,269,563 2,269,563
16% 16%
100%
- Direct Costs 648,606 648,606
10% 10%
29%
1,620,957 1,620,957
19% 19%
71%
- Selling and Administrative Expenses 817,753 817,753
20% 20%
36%
- Research and Development Expense 312,312 312,312
5% 5%
14%
490,892 490,892
28% 28%
22%
- Depreciation and Amortization 107,923 107,923
14% 14%
5%
EBIT (Operating Income) EBIT 382,969 382,969
33% 33%
17%
Net Profit 151,575 151,575
18% 18%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Tatsuo Higuchi
Employees 34,388
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today